Mmc Pharmaceuticals Limited, a active public limited company, was established on 18 March 2016 in Chennai, Tamil Nadu, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24100TN2016PLC104768. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹7.00 M and a paid-up capital of ₹6.13 M.
It upholds a compliant status. Employing 281 professional, Its leadership includes Shanthi (Director), Rajarathinam Vallab Subash (Director), Sureshbabu Makam (Director). Past directors included Sureshbabu Makam, Mariappan Ravichandran, Ramasamy Savrirajan Jayaraman. It holds ₹9.60 Cr open charges and ₹2.35 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at No: 113, Visalakshi Street Devi Karumariamman Nagar, Valasaravakkam, Chennai, Tamil Nadu, 600087.
U24100TN2016PLC104768
104768
18 March 2016
₹7.00 M
₹6.13 M
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Mmc Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shanthi | Director | 18 Mar 2016 | Current |
| Rajarathinam Vallab Subash | Director | 18 Mar 2016 | Current |
| Sureshbabu Makam | Director | 24 Dec 2018 | Current |
| Malliah Rajarathinam | Managing Director | 18 Mar 2016 | Current |
| Girijadevi Jayaraman | Director | 21 Mar 2016 | Current |
| Malliah Vidyavathi | Director | 21 Mar 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 24 Sep 2019 | Past |
| Pramod Abcsdd | Director | 09 Sep 2024 | Past |
| Pramod Abcsdd | Director | 10 Jun 2021 | Past |
| Pramod Abcsdd | Director | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Mmc Pharmaceuticals Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 7.72% increase. The company also saw a substantial improvement in profitability, with a 23.25% increase in profit. The company's net worth Soared by an impressive increase of 16.73%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Mmc Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹96,000,000.00
₹23,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 May 2018 | Others | ₹9.60 Cr | Open |
| 27 Mar 2017 | State Bank Of India | ₹2.35 Cr | Satisfied |
Explore comprehensive loan charge details -
Mmc Pharmaceuticals has a workforce of 281 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Mmc Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mmc Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with Others of Rs. 96.00 M registered on 25 May 2018 with Charge ID 100198603 was modified on 21 Mar 2025. was completed.
Mmc Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Mmc Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was completed.
The activity Sureshbabu Makam was appointed as a Director was appointed as a Director on 24 Dec 2018 & has been associated with this company since 7 years 21 days . was completed.
The activity A charge registered on 27 Mar 2017 via Charge ID 100127022 with State Bank Of India was fully satisfied on 02 Jun 2018. was completed.
The activity A charge with Others amounted to Rs. 96.00 M with Charge ID 100198603 was registered on 25 May 2018. was completed.
The CIN of Mmc Pharmaceuticals Limited is U24100TN2016PLC104768.
Mmc Pharmaceuticals Limited is headquartered at No: 113, Visalakshi Street Devi Karumariamman Nagar, Valasaravakkam, Chennai, Tamil Nadu, 600087.
Mmc Pharmaceuticals Limited was incorporated on 18 March 2016.
The current directors of Mmc Pharmaceuticals Limited are
The primary industry of Mmc Pharmaceuticals Limited is Trade.
Mmc Pharmaceuticals Limited is unlisted.
The authorized capital of Mmc Pharmaceuticals Limited is ₹7.00 M, and the paid-up capital is ₹6.13 M.
The compliance status of Mmc Pharmaceuticals Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX